- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05494645
Exparel Use in Peripheral Nerve Blocks and Local Infiltration for Foot and Ankle Surgery: A Randomized Controlled Trial
August 8, 2022 updated by: St. Luke's Hospital, Pennsylvania
Liposomal Bupivacaine (Exparel) has been recently studied as the active agent utilized in various nerve block.
Due to its liposomal form allowing for extended delivery, Exparel has been used in various peri-operative nerve blocks among multiple orthopaedic specialties in hopes of achieving improved pain control and decreased opioid use.
This study compares the efficacy and effect on opioid use of peripheral nerve blocks and local infiltration with and without Exparel in patients undergoing foot and ankle surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
three study groups: A - surgeon infiltrates with exparel on site of surgery; B - anesthesia provides a regional nerve block (popliteal/adductor blocks) with plain local anesthetic (bupivacaine); C - anesthesia provides a regional nerve block (popliteal/adductor) with Exparel/bupivacaine mix.
Follow up occurs on postop day 4 via phone call to patient.
Measured outcomes include opioid consumption in post anesthesia care unit phase (oral morphine equivalents), block duration, number of opioid pills used by postop day 4, oral morphine equivalent consumption by postop day 4.
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anna Ng-Pellegrino
- Phone Number: 610-954-4000
- Email: anna.ngpellegrino@sluhn.org
Study Locations
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, United States, 18015
- Recruiting
- St. Luke's University Health network
-
Contact:
- Brendan Smith, MD
- Phone Number: 484-526-8290
- Email: Brendan.smith@sluhn.org
-
Sub-Investigator:
- Brendan Smith, MD
-
Sub-Investigator:
- Ajith Malige, MD
-
Principal Investigator:
- James Lachman, MD
-
Principal Investigator:
- Anna Ng Pellegrino, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult patients undergoing elective orthopaedic foot and ankle surgery at a single institution
- English speaking
- Able to provide consent to surgery and study participation
Exclusion Criteria:
- Non-elective or emergent foot and ankle surgery
- Non-english speaking
- Does not possess medical decision making capacity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Peripheral Nerve Block Without Exparel
Lower extremity peripheral nerve block without Exparel: 0.25-0.5% bupivacaine
|
Peripheral nerve block without Exparel
Other Names:
|
Experimental: Peripheral Nerve Block with Exparel
Liposomal bupivicaine administered for peripheral nerve block: mixed with 0.25-0.5% bupivacaine
|
Liposomal bupivicaine
Other Names:
|
Experimental: Local Infiltration of Exparel
Liposomal bupivicaine administered by surgeon intra-operatively in field block, mix with 0.25% bupivacaine
|
Liposomal bupivicaine
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Duration of block
Time Frame: 3 Months
|
3 Months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
number of opioid pills used by postoperative day # 4
Time Frame: 3 months
|
3 months
|
PROMIS Scores
Time Frame: 3 months
|
3 months
|
oral morphine equivalent use by postoperative day 4
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Anna Ng-Pellegrino, St. Luke's Hospital and Health Network, Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2022
Primary Completion (Anticipated)
June 1, 2023
Study Completion (Anticipated)
December 31, 2023
Study Registration Dates
First Submitted
August 8, 2022
First Submitted That Met QC Criteria
August 8, 2022
First Posted (Actual)
August 10, 2022
Study Record Updates
Last Update Posted (Actual)
August 10, 2022
Last Update Submitted That Met QC Criteria
August 8, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Fractures, Bone
- Wounds and Injuries
- Leg Injuries
- Pain, Postoperative
- Acute Pain
- Ankle Injuries
- Ankle Fractures
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anesthetics, Local
- Bupivacaine
Other Study ID Numbers
- SLRI-2022-24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalRecruitingPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
Hospital of South West JutlandNovo Nordisk A/SNot yet recruitingPhysical Activity | Postoperative Pain, Acute | Postoperative Pain, Chronic | Bariatric Surgery | MobilizationDenmark
-
University of ManitobaUnknown
Clinical Trials on Peripheral Nerve Block
-
Diskapi Yildirim Beyazit Education and Research...Recruiting
-
Ain Shams UniversityRecruiting
-
Kevin King, DOCompletedPain, Postoperative | Total Knee Arthroplasty (TKA)United States
-
Slocum Research & Education FoundationSlocum Center for Orthopedics & Sports MedicineUnknownAnkle Arthropathy | Ankle ArthritisUnited States
-
Smiths Medical, ASD, Inc.UnknownPeripheral Nerve Block ProcedureUnited Kingdom
-
LifeBridge HealthRubin Institute for Advanced OrthopedicsRecruitingHip Osteoarthritis | Hip ArthropathyUnited States
-
Chicago Anesthesia Pain SpecialistsCompletedKnee ArthroplastyUnited States
-
Severance HospitalRecruitingCough | Thoracic Surgery | Nerve BlockKorea, Republic of
-
Saint Francis CareCompleted
-
Vinmec Healthcare SystemWithdrawn